Tarivid eye drops
Marketed by Ferron Par Pharmaceuticals
Ingredients in every ml
| Ofloxacine | 3 mg |
Each package contains
Other details
| Flavour | None |
W.H.O. classification
| ATC Level 1 | S - Sensory organs |
| ATC Level 2 | S01 - Ophthalmologicals |
| ATC Level 3 | S01A - Antiinfective Ophthalmologics |
Warnings
Pregnancy
Lactation
Alcohol
Machinery
Available in
 |
Indonesia |
Dosage information
OTHER DETAILS
Treatment of bacterial conjunctivitis:
days 1 and 2: instill one to two drops every two to four hours in the affected eye.
Day 3 through 7: instill one to two drops four times daily.
Treatment of bacterial corneal ulcer:
days 1 and 2: instill one to two drops in to the affected eye every 30 minutes, while a wake, awaken at approximately four and six hours after refring & instill one to two drops.
Day 3 through 7 to 9: instill one to two drops hourly, while awake
Day 7 to 9 through treatment completion: instill one to two drops, four times daily
Indication
The following infections caused by ofloxacin-susceptible strains of Staphylococcus dp, Streptococcus sp, Streptococcus pneumoniae, Micrococcus sp, Corynebacterium sp, Branhamella catarrhalis, Pseudomonas sp, Pseudomonas aeruginosa, Haemiphillus sp. (H. influenzae, H. segyptius (Koch-Weeks bacillus), Moraxela sp (Morax-Axenfeld diplobacillus), Serratia sp, Klebsiella sp, Proteus sp, Acinetobacter sp) and Anaerobic bacteria (Propionibacterium acnes): blepharitis, dacryocysitis, conjunctivitis, tarsadensitis, keratitis and corneal ulcer.